≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Oral lichen ruber planus, including avohilmo

Endpoint Browser

K11_ORAL_LICHEN_PLANUS_INCLAVO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — K13.74
  • Hospital discharge: ICD-10 — K13.74
  • Cause of death: ICD-10 — K13.74

3 out of 7 registries used, show all original rules.

2144

4. Check minimum number of events

None

2144

5. Include endpoints

None

2144

6. Filter based on genotype QC (FinnGen only)

2144

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 2144 1662 482
Unadjusted period prevalence (%) 0.49 0.57 0.21
Median age at first event (years) 64.22 64.28 64.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1837
Matched controls
18368
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EKA10
NOMESCO Finland
Biopsy of cheek
71.7
323.0
644
137
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
28.4
323.0
533
260
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
+∞
323.0
1837
*
SAA03
NOMESCO Finland
Extended examination of mouth
7.1
319.3
1332
4989
L43.8
ICD-10 Finland
Other lichen planus
37.5
312.7
404
137
L43.9
ICD-10 Finland
Lichen planus, unspecified
32.1
272.6
366
141
SBA00
NOMESCO Finland
Microbiological examinations
24.8
255.4
370
185
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
21.0
214.8
328
188
WZB00
NOMESCO Finland
Telephone receipt or other advice
4.6
193.1
961
3546
SAA01
NOMESCO Finland
Simple examination of mouth
6.1
175.4
1645
10755
SAA02
NOMESCO Finland
Basic examination of mouth
4.9
172.1
1544
9475
K13.78
ICD-10 Finland
Other change in the oral mucosa
17.7
166.8
270
177
ECA20
NOMESCO Finland
Biopsy of gingiva
41.6
162.2
204
55
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
19.5
151.4
236
138
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
145.9
980
4363
D07AC01
ATC
betamethasone; topical
3.6
140.6
975
4409
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
3.3
127.4
1025
5056
SXA10
NOMESCO Finland
Epithel biopsy of mouth
24.2
123.3
178
81
L43
ICD-10 Finland
Lichen planus
23.1
120.1
176
84
K13.29
ICD-10 Finland
Indefinite leukoplakia
24.2
115.1
166
75
WX110
NOMESCO Finland
Local anesthesy
3.6
111.7
1517
10432
D07AD01
ATC
clobetasol; topical
3.7
104.8
571
2013
SDA02
NOMESCO Finland
Parodonthologic therapy
3.0
99.7
869
4272
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.9
99.3
1229
7549
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.8
95.7
1110
6474
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
2.7
86.7
1281
8398
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.7
85.6
1256
8167
K02.1
ICD-10 Finland
Caries of dentine
2.7
85.3
1243
8040
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.0
84.7
252
474
L43.0
ICD-10 Finland
Hypertrophic lichen planus
43.2
82.0
102
25
Z01.2
ICD-10 Finland
Dental examination
2.6
81.2
984
5659
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.5
79.3
1079
6582
KMAK
NOMESCO Finland
NA
2.5
77.3
1146
7280
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.5
77.0
964
5582
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
2.8
75.2
642
2974
A07AA02
ATC
nystatin; oral
4.6
72.4
274
671
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.4
69.2
1081
6872
SDA01
NOMESCO Finland
Simple parodonthologic therapy
2.5
62.0
628
3133
L43.3
ICD-10 Finland
Subacute (active) lichen planus
66.1
60.8
70
11
K03.64
ICD-10 Finland
Dental calculus supragingival
2.4
59.0
665
3494
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
2.4
59.0
645
3337
D20
ICPC
Mouth/tongue/lip symptom/complaint
5.5
58.6
184
364
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.1
57.7
194
415
R01AD11
ATC
triamcinolone; nasal
3.4
56.6
316
1072
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
4.1
51.8
217
578
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.4
48.8
190
471
B37.08
ICD-10 Finland
Other candidal stomatitis
19.7
48.7
74
39
-1
NOMESCO Finland
NA
2.2
47.9
699
4052
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.3
47.7
584
3124
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
2.3
46.8
582
3129
D82
ICPC
Teeth/gum disease
2.1
45.4
739
4463
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.0
45.1
886
5776
WZA90
NOMESCO Finland
Other doctors statement
2.2
43.1
528
2800
K05.30
ICD-10 Finland
Periodontitis complex
2.7
43.0
336
1408
VALMI
NOMESCO Finland
NA
2.2
42.5
537
2885
J02AC01
ATC
fluconazole; systemic
1.9
40.2
931
6358
L28.0
ICD-10 Finland
Lichen simplex chronicus
12.2
39.7
73
62
D19
ICPC
Teeth/gum symptom/complaint
2.1
39.6
579
3293
WX290
NOMESCO Finland
Other blockade of nerve
1.9
38.2
859
5765
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
23.7
37.2
53
23
EJ2S1
NOMESCO Finland
Photography of oral mucosa
28.5
36.9
50
18
K13.20
ICD-10 Finland
Idiopathic leukoplakia
21.0
35.8
53
26
SFA00
NOMESCO Finland
Small filling
2.4
34.6
321
1464
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.5
34.0
305
1365
A01AC01
ATC
triamcinolone; local oral
5.9
31.5
90
158
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
10.5
30.5
60
59
XQ802
NOMESCO Finland
Epicutan test
3.9
30.4
131
355
EBA00
NOMESCO Finland
Extraction of tooth
1.9
30.0
630
4026
SBB10
NOMESCO Finland
Teeth copy
3.3
29.9
159
510
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
17.4
29.3
46
27
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.6
29.2
226
927
R01AD09
ATC
mometasone; nasal
1.8
29.1
896
6465
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
40.8
29.0
36
9
A01AB09
ATC
miconazole; local oral
2.6
28.9
233
978
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
28.6
523
3169
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.0
28.5
423
2367
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
27.7
28.0
38
14
SXC05
NOMESCO Finland
Other oral or dental procedure
3.2
27.7
152
499
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.4
27.4
259
1182
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.6
27.1
96
216
TEA00
NOMESCO Finland
Biopsy of lip
9.3
26.8
56
62
E0000UV
ATC
NA
1.7
26.5
761
5322
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
4.0
26.4
109
284
EMAK
NOMESCO Finland
NA
3.8
26.3
116
321
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
37.3
26.2
33
9
K05.31
ICD-10 Finland
Periodontitis pronounced
2.4
26.1
233
1031
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.5
25.3
211
899
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.5
25.3
220
960
K02.0
ICD-10 Finland
Caries limited to enamel
2.2
25.0
276
1354
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
18.4
24.8
38
21
A02BC05
ATC
esomeprazole; systemic
1.7
24.7
814
5889
D07AC13
ATC
mometasone; topical
1.8
24.2
579
3798
K05.18
ICD-10 Finland
Chronic gingivitis
3.2
23.9
130
424
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
13.1
23.4
41
32
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.7
23.1
166
648
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
23.0
552
3615
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
22.9
361
2047
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
22.3
468
2930
L43.1
ICD-10 Finland
Bullous lichen planus
39.1
21.7
27
7
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.8
21.6
432
2658
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.7
21.2
94
262
K05.1
ICD-10 Finland
Chronic gingivitis
2.6
21.1
166
685
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.7
20.7
519
3425
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.2
20.5
226
1104
K12.10
ICD-10 Finland
Stomatitis NOS
10.2
20.4
40
40
K03.66
ICD-10 Finland
Tooth plaque
2.6
20.1
150
600
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.8
20.1
135
508
A02BC02
ATC
pantoprazole; systemic
1.6
19.8
1204
9984
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
106.2
19.6
21
*
M01AH05
ATC
etoricoxib; oral
1.6
19.6
1128
9210
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
19.2
212
1034
ULA02
NOMESCO Finland
Kolposcopy
2.2
19.1
207
1003
K12.18
ICD-10 Finland
Other forms of stomatitis
7.1
18.9
46
66
EJ2S1
SPAT
NA
44.5
18.2
22
5
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.3
18.2
172
778
L01
ICPC
Neck symptom/complaint
1.9
18.0
279
1560
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.1
17.7
206
1025
EKC00
NOMESCO Finland
Suture of cheek
37.1
17.6
22
6
L44.3
ICD-10 Finland
Lichen ruber moniliformis
50.5
17.0
20
*
K12.00
ICD-10 Finland
Recurrent oral aphthae
5.6
17.0
49
89
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
17.0
364
2268
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
16.9
528
3664
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
16.3
147
652
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
16.0
805
6237
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
14.6
15.8
26
18
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
15.8
393
2555
SXC03
NOMESCO Finland
Other oral or dental procedure
6.2
15.8
42
69
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.9
15.7
240
1332
M03BX02
ATC
tizanidine; oral
1.5
15.6
1164
9811
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
19.4
15.6
23
12
WKPAL
NOMESCO Finland
NA
4.1
15.5
60
149
SBA10
NOMESCO Finland
Measurement of excretion of saliva
5.8
15.4
43
75
EHA10
NOMESCO Finland
Biopsy of palate
7.6
15.2
35
47
R01AD12
ATC
fluticasone furoate; nasal
1.6
15.1
541
3863
M25.5
ICD-10 Finland
Pain in joint
1.6
14.9
540
3864
R06AE07
ATC
cetirizine; oral
1.5
14.9
814
6392
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
14.5
197
1045
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.5
14.4
68
201
N89.5
ICD-10 Finland
Stricture and atresia of vagina
15.5
14.4
23
15
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
5.8
14.4
40
70
PAD
NOMESCO Finland
NA
27.4
14.3
19
7
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
14.2
250
1458
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
14.1
468
3268
M79.6
ICD-10 Finland
Pain in limb
1.5
14.1
639
4799
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.6
14.0
106
428
D05BB02
ATC
acitretin; oral
3.5
13.9
64
186
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.1
13.9
153
746
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.9
13.9
224
1267
L08
ICPC
Shoulder symptom/complaint
1.7
13.8
359
2353
EDB00
NOMESCO Finland
Partial excision of mandible
20.2
13.8
20
10
A98
ICPC
Health maint/preventive medicine
2.6
13.7
1784
17049
A01AB04
ATC
amphotericin B; local oral
2.5
13.6
110
461
F45.8
ICD-10 Finland
Other somatoform disorders
2.3
13.6
134
620
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
13.5
180
949
U02
ICPC
Urinary frequency/urgency
1.8
13.5
264
1592
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.9
13.5
221
1257
R03AC02
ATC
salbutamol; inhalant
1.5
13.4
933
7636
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.6
13.4
98
389
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
2.0
13.3
178
939
R06AX27
ATC
desloratadine; oral
1.5
13.2
484
3458
R01AD08
ATC
fluticasone; nasal
1.5
13.1
532
3884
A02BC03
ATC
lansoprazole; oral
1.5
13.1
540
3959
H03AA01
ATC
levothyroxine sodium; systemic
1.5
13.1
471
3348
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
13.0
437
3053
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.9
13.0
197
1089
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
11.6
12.8
23
20
N02BE01
ATC
paracetamol; systemic, rectal
1.6
12.5
1554
14224
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.4
12.4
1014
8507
R01AD01
ATC
beclometasone; nasal
1.7
12.4
299
1916
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
12.2
209
1203
LEB00
NOMESCO Finland
Biopsy of vagina
3.4
12.2
58
174
G01AA10
ATC
clindamycin; vaginal
1.6
12.1
319
2094
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
11.9
193
1091
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
8.0
11.8
26
33
TUPEI
NOMESCO Finland
NA
2.7
11.6
77
289
R13
ICD-10 Finland
Dysphagia
2.2
11.6
123
589
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
9.3
11.5
23
25
R09
ICPC
Sinus symptom/complaint
2.0
11.4
148
771
HMAK
NOMESCO Finland
NA
1.8
11.4
219
1308
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
11.3
106
479
J01AA02
ATC
doxycycline; systemic
1.5
11.3
1422
12830
M79.1
ICD-10 Finland
Myalgia
1.7
11.2
232
1418
L03
ICPC
Low back symptom/complaint
1.5
11.2
429
3078
S18
ICPC
Laceration/cut
1.4
11.2
721
5746
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
11.1
223
1351
S29
ICPC
Skin symptom/complaint other
1.6
11.0
292
1912
XQ800
NOMESCO Finland
Prick test
2.0
10.9
138
713
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
10.8
393
2780
L17
ICPC
Foot/toe symptom/complaint
1.5
10.8
439
3187
J01DB01
ATC
cefalexin; oral
1.5
10.8
1440
13064
K03.00
ICD-10 Finland
Approximal wear
2.3
10.7
97
432
N77.8
ICD-10 Finland
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
28.2
10.7
14
5
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
2.3
10.7
97
433
K08.80
ICD-10 Finland
Toothache NOS
1.9
10.7
158
865
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
10.7
260
1664
K05.12
ICD-10 Finland
Gingivitis (chronic) simple marginal
21.6
10.7
15
7
N03AX16
ATC
pregabalin; oral
1.5
10.7
432
3133
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.8
10.6
186
1078
R05
ICPC
Cough
1.5
10.5
387
2746
TLE00
NOMESCO Finland
Dilatation of vagina
110.6
10.4
11
*
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
4.3
10.4
37
87
H02AB06
ATC
prednisolone; systemic
1.4
10.4
804
6593
P06
ICPC
Sleep disturbance
1.8
10.3
170
966
EKB00
NOMESCO Finland
Excision of lesion of cheek
7.1
10.3
24
34
K14.61
ICD-10 Finland
Glossodynia
5.5
10.3
29
53
L43.2
ICD-10 Finland
Lichenoid drug reaction
18.9
10.3
15
8
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.3
739
5982
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
6.7
10.2
25
38
EAA10
NOMESCO Finland
Excision of lesion of lip
4.4
10.1
35
80
E000001
ATC
NA
1.5
10.1
353
2473
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
10.1
170
975
A02BC04
ATC
rabeprazole; oral
1.8
10.1
170
976
J01FA10
ATC
azithromycin; systemic
1.4
10.1
1028
8818
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.8
10.1
173
998
K11.70
ICD-10 Finland
Hypoptyalism
6.1
10.0
26
43
R06AE09
ATC
levocetirizine; oral
1.6
10.0
256
1663
D07AB08
ATC
desonide; topical
1.8
9.9
184
1088
UJF32
NOMESCO Finland
Coloscopy
1.5
9.9
443
3271
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
4.6
9.9
33
73
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
3.5
9.9
45
132
ECA30
NOMESCO Finland
Excision of lesion of gingiva
5.1
9.9
30
60
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.5
9.8
76
311
C05AA08
ATC
fluocortolone; rectal, topical
1.6
9.8
266
1754
K07.60
ICD-10 Finland
Snapping jaw
2.2
9.8
98
459
M01AE02
ATC
naproxen; oral, rectal
1.4
9.7
995
8518
N06AA09
ATC
amitriptyline; systemic
1.7
9.7
202
1239
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.9
9.7
148
821
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
9.7
157
888
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
9.7
600
4714
N02AX02
ATC
tramadol; systemic, rectal
1.4
9.6
704
5696
B37.0
ICD-10 Finland
Candidal stomatitis
4.3
9.5
34
81
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
100.5
9.4
10
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
100.5
9.4
10
*
EJB40
NOMESCO Finland
Hemiglossectomy
30.2
9.4
12
*
Z01.9
ICD-10 Finland
Special examination, unspecified
2.1
9.4
110
553
J01DA01
ATC
[U] cefalexin; systemic
1.4
9.3
1070
9302
K13.1
ICD-10 Finland
Cheek and lip biting
6.5
9.3
23
36
R52.9
ICD-10 Finland
Pain, unspecified
1.8
9.2
148
835
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
9.2
257
1702
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
9.2
153
871
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
9.2
441
3298
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
3.1
9.2
49
162
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
9.2
1610
15079
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.8
9.2
172
1018
D83
ICPC
Mouth/tongue/lip disease
6.7
9.1
22
33
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
3.9
9.1
36
94
K03.80
ICD-10 Finland
Irradiated enamel
2.1
9.1
98
474
R06AX22
ATC
ebastine; oral
1.5
9.1
315
2202
K03.1
ICD-10 Finland
Abrasion of teeth
2.7
9.1
61
232
K07.23
ICD-10 Finland
Deep bite
3.5
9.1
40
115
L15
ICPC
Knee symptom/complaint
1.5
9.0
363
2616
E000006
ATC
NA
1.9
9.0
139
773
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
10.1
9.0
17
17
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.7
9.0
184
1119
EBB10
NOMESCO Finland
Insertion of dental implant
3.5
9.0
40
116
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
18.7
8.9
13
7
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
8.9
116
606
K14.9
ICD-10 Finland
Disease of tongue, unspecified
12.6
8.9
15
12
G47.3
ICD-10 Finland
Sleep apnoea
1.5
8.8
327
2316
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
8.8
355
2561
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
8.7
286
1970
S02.51
ICD-10 Finland
Fracture of tooth, open
1.7
8.6
185
1144
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.2
8.6
87
410
J01CA04
ATC
amoxicillin; systemic
1.4
8.5
1397
12767
A07EA02
ATC
hydrocortisone; rectal
3.0
8.5
46
154
K13.7
ICD-10 Finland
Other and unspecified lesions of oral mucosa
9.0
8.5
17
19
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
8.5
278
1914
R74
ICPC
Upper respiratory infection acute
1.4
8.4
444
3371
S08
ICPC
Skin colour change
2.2
8.3
86
410
XQ848
NOMESCO Finland
Dermatological photography
2.8
8.3
50
180
K14.60
ICD-10 Finland
Glossopyrosis
6.2
8.3
21
34
D06BX01
ATC
metronidazole; topical
1.6
8.2
196
1246
R05
ICD-10 Finland
Cough
1.5
8.2
332
2390
H13
ICPC
Plugged feeling ear
1.5
8.2
282
1963
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
8.2
85
405
SPA02
NOMESCO Finland
Preparation for dental prosthetics
2.8
8.2
49
176
N03AX12
ATC
gabapentin; oral
1.5
8.1
272
1881
-60
ICPC
Result test/procedure
2.0
8.1
102
529
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.4
8.0
63
265
EB1MA
NOMESCO Finland
Cephalometry with X-ray
3.8
7.9
32
86
S21
ICPC
Skin texture symptom/complaint
1.6
7.9
208
1354
G44.2
ICD-10 Finland
Tension-type headache
1.6
7.9
236
1588
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
7.9
784
6597
LFA00
NOMESCO Finland
Incision of vulva or perineum
10.8
7.8
14
13
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
7.8
351
2583
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.9
7.8
115
630
SPC01
NOMESCO Finland
Fixed dental crown
3.6
7.8
33
93
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.8
7.7
31
83
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.0
7.7
91
461
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
7.7
82
398
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.3
7.7
71
320
R07.0
ICD-10 Finland
Pain in throat
1.9
7.6
102
539
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.5
7.6
33
95
J05AB01
ATC
aciclovir; systemic
1.4
7.5
366
2730
N06AX11
ATC
mirtazapine; oral
1.4
7.5
532
4239
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
7.5
165
1030
SPAT1301
SPAT
No procedures
1.4
7.4
504
3987
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
80.4
7.4
8
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
7.4
849
7266
SPAT1312
SPAT
General health counselling
1.4
7.4
509
4036
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
7.7
7.4
16
21
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
7.7
7.4
16
21
SPAT1153
SPAT
Removal of sutures
1.4
7.4
537
4297
SPB06
NOMESCO Finland
Production of temporary clinic-made tooth- or implant-retained crown or bridge unit
6.0
7.4
19
32
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
7.3
494
3901
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
4.7
7.3
23
49
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.3
522
4159
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
7.3
399
3041
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
9.4
7.3
14
15
R21
ICPC
Throat symptom/complaint
1.5
7.2
285
2041
L04
ICPC
Chest symptom/complaint
1.9
7.2
95
502
SPAT1263
SPAT
Sampling
1.3
7.2
686
5714
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
7.1
207
1385
K12
ICD-10 Finland
Stomatitis and related lesions
12.1
7.1
12
10
J02AC02
ATC
itraconazole; systemic
1.4
7.0
322
2375
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
2.8
7.0
41
146
D01AE16
ATC
amorolfine; topical
1.6
7.0
195
1295
N06AB10
ATC
escitalopram; oral
1.4
7.0
308
2255
L66.1
ICD-10 Finland
Lichen planopilaris
13.8
6.9
11
8
107
Kela drug reimbursment
Pernicious anaemia
3.2
6.9
34
109
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
6.8
100
548
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
3.4
6.8
30
88
M01AB05
ATC
diclofenac; systemic, rectal
1.3
6.8
1168
10519
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
6.8
308
2268
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
6.8
188
1243
K30
ICD-10 Finland
Functional dyspepsia
1.6
6.7
185
1219
M54.6
ICD-10 Finland
Pain in thoracic spine
1.8
6.7
114
656
N06AX21
ATC
duloxetine; oral
1.6
6.7
185
1224
M01AX05
ATC
glucosamine; oral
1.4
6.7
351
2653
A07EA06
ATC
budesonide; oral, local oral
2.3
6.7
59
262
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
6.7
295
2158
D02AE01
ATC
carbamide; topical
1.8
6.6
115
667
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
6.6
475
3780
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.6
495
3967
K60.1
ICD-10 Finland
Chronic anal fissure
2.5
6.6
47
188
K13.6
ICD-10 Finland
Irritative hyperplasia of oral mucosa
4.0
6.6
24
60
S02
ICPC
Pruritus
2.3
6.6
56
246
N05CF02
ATC
zolpidem; oral
1.4
6.6
312
2316
L12
ICPC
Hand/finger symptom/complaint
1.5
6.5
231
1621
EAV
NOMESCO Finland
NA
3.0
6.5
35
120
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
6.4
211
1454
K05.08
ICD-10 Finland
Another acute gingivitis
2.4
6.4
49
204
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
6.4
202
1378
R35
ICD-10 Finland
Polyuria
1.9
6.4
85
453
P01BA02
ATC
hydroxychloroquine; oral
1.6
6.3
158
1020
A02BA02
ATC
ranitidine; systemic
1.4
6.3
319
2394
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
6.3
326
2455
B81
ICPC
Anaemia vit B12/folate deficiency
2.2
6.3
59
271
R07.3
ICD-10 Finland
Other chest pain
1.6
6.3
153
983
EJA10
SPAT
NA
+∞
6.3
6
*
L13
ICPC
Hip symptom/complaint
1.4
6.2
278
2038
K02.2
ICD-10 Finland
Caries of cementum
2.0
6.2
73
369
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.5
6.2
184
1235
L12.8
ICD-10 Finland
Other pemphigoid
26.8
6.2
8
*
M79.7
ICD-10 Finland
Fibromyalgia
2.1
6.2
68
334
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.8
6.2
36
128
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
6.2
351
2684
WX110
SPAT
NA
2.0
6.2
77
401
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
6.2
91
504
K13.03
ICD-10 Finland
Keilit UNS
7.7
6.1
13
17
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
4.7
6.1
19
41
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.1
566
4673
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.0
199
1369
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
6.0
598
4980
S02.53
ICD-10 Finland
Fracture of tooth root
2.3
6.0
52
230
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.5
6.0
43
173
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.0
678
5741

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
322
243
15.42
307.65
2.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1293
7994
2.56
95.18
2.5
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
548
2236
2.95
94.17
1.9
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
225
833
2.90
44.06
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
197
773
2.71
34.34
1.3
1.2
u/ml
0.6
1.6
1.05
12
65
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1764
14957
2.01
33.18
5.1
4.3
pmol/l
14.8
14.8
0.41
1611
13634
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
62
118
5.38
31.14
1.4
1.3
titre
28.6
65.0
—
7
12
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
67
139
4.94
30.53
1.7
1.4
u/ml
22.5
22.6
0.00
19
28
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
636
4154
1.76
28.70
1.3
1.2
u/ml
2.1
1.5
0.37
180
1117
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1946
17420
2.27
27.09
6.3
5.1
mu/l
1.9
2.1
1.05
1794
15961
(3037522) Nuclear Ab [Titer] in Serum
440
2648
1.83
25.81
1.5
1.3
titre
620.2
549.2
0.29
105
572
(3013707) Erythrocyte sedimentation rate by Westergren method
1656
14119
1.76
25.79
4.9
4.2
mm/h
12.2
12.5
0.32
1544
13083
(3007164) IgA [Mass/volume] in Serum or Plasma
551
3589
1.72
24.46
1.4
1.4
g/l
2.4
2.4
0.03
337
2149
(40768797) Stomach Pathology biopsy report
449
2810
1.76
22.78
1.4
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
140
569
2.56
22.62
1.3
1.2
u/ml
10.1
31.3
—
6
38
(3048689) Calprotectin [Mass/mass] in Stool
370
2238
1.79
20.94
2.3
2.2
ug/g
140.3
126.3
0.24
290
1780
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
984
7617
1.54
20.62
2.1
1.9
pmol/l
100.1
97.3
0.98
449
3707
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1679
14670
1.67
20.44
7.5
7.8
u/l
75.2
78.5
2.92
1586
13816
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1916
17436
1.93
19.53
6.1
5.7
mmol/mol
39.1
39.7
2.35
1783
16139
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
109
427
2.64
18.98
1.3
1.2
u/ml
56.6
50.2
0.12
12
54
(3001122) Ferritin [Mass/volume] in Serum or Plasma
982
7735
1.50
18.14
3.0
2.8
ug/l
102.9
120.3
2.05
916
7163
(3006315) Basophils [#/volume] in Blood
1144
9308
1.49
17.92
6.2
5.9
e9/l
0.0
0.0
0.26
1007
8035
(3037467) Urinalysis macro (dipstick) panel - Urine
1480
12708
1.53
17.77
4.9
4.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1138
9271
1.48
17.57
6.2
5.9
e9/l
0.5
0.6
3.32
1006
7999
(3019198) Lymphocytes [#/volume] in Blood
1160
9496
1.48
17.41
6.2
6.0
e9/l
1.9
1.9
1.66
1034
8367
(3021960) Folate [Moles/volume] in Serum or Plasma
590
4200
1.56
17.38
1.5
1.5
nmol/l
21.9
21.4
0.33
507
3542
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
122
531
2.38
17.01
1.3
1.2
u/ml
2.8
10.0
1.74
20
99
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
120
523
2.37
16.69
1.3
1.2
u/ml
7.6
8.0
0.03
13
61
(3013115) Eosinophils [#/volume] in Blood
1170
9643
1.47
16.64
6.3
6.1
e9/l
0.2
0.2
0.04
1043
8456
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1979
18375
2.00
16.51
5.2
4.6
mmol/l
5.9
5.9
0.33
1808
16764
(3023103) Potassium [Moles/volume] in Serum or Plasma
2052
19371
2.38
15.48
15.6
15.9
mmol/l
4.0
4.0
0.07
2005
18875
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1999
18696
2.02
15.23
5.1
4.6
mmol/l
4.8
4.8
1.45
1848
17299
(3019550) Sodium [Moles/volume] in Serum or Plasma
2046
19316
2.30
14.99
15.5
15.7
mmol/l
139.7
139.7
0.02
2001
18851
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
98
410
2.46
14.93
1.3
1.2
u/ml
1.1
4.8
—
9
30
(36660697) Celiac disease serology panel - Serum
250
1483
1.78
14.84
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2024
19037
2.13
14.83
5.6
5.1
mmol/l
2.8
2.8
0.36
1856
17534
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1985
18561
1.94
14.52
5.0
4.5
mmol/l
1.5
1.5
0.04
1818
17075
(3024731) MCV [Entitic volume]
2127
20516
5.64
14.47
21.9
20.7
fl
91.2
91.1
0.19
2106
20241
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1980
18504
1.92
14.43
14.1
14.0
mg/l
18.8
22.4
5.82
1553
14602
(3006504) Eosinophils/100 leukocytes in Blood
1057
8684
1.43
14.43
6.3
6.0
%
3.0
2.8
1.76
992
8070
(3026361) Erythrocytes [#/volume] in Blood
2127
20519
5.62
14.40
22.0
20.7
e12/l
4.5
4.5
1.56
2082
19961
(3010813) Leukocytes [#/volume] in Blood
2127
20520
5.61
14.38
22.0
20.8
e9/l
6.3
6.6
10.14
2080
19961
(3019069) Monocytes/100 leukocytes in Blood
1061
8727
1.43
14.37
6.7
6.3
%
8.7
8.5
0.95
1003
8152
(3018010) Neutrophils/100 leukocytes in Blood
1069
8808
1.43
14.32
6.2
5.9
%
55.8
56.8
2.45
1004
8218
(3000963) Hemoglobin [Mass/volume] in Blood
2127
20526
5.57
14.24
22.1
20.8
g/l
135.3
134.2
3.64
2105
20251
(3002030) Lymphocytes/100 leukocytes in Blood
1082
8943
1.42
14.19
6.4
6.1
%
29.4
28.4
2.68
1016
8307
(3035941) MCH [Entitic mass]
2126
20518
5.31
14.05
21.9
20.6
pg
30.3
30.3
1.16
2105
20241
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1005
8209
1.42
14.03
2.4
2.3
nmol/l
80.2
79.2
0.55
916
7389
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
499
3566
1.52
13.98
1.4
1.3
iu/ml
34.1
35.7
0.09
166
1148
(3022096) Basophils/100 leukocytes in Blood
1029
8452
1.42
13.85
6.4
6.1
%
0.7
0.7
2.22
970
7862
(3007461) Platelets [#/volume] in Blood
2125
20512
5.06
13.81
22.0
20.7
e9/l
253.5
257.1
1.89
2087
20016
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
477
3385
1.53
13.79
1.4
1.3
u/ml
14.8
11.9
0.28
161
1336
(3031040) Bacteria [#/volume] in Urine by Automated count
1398
12163
1.43
13.35
4.9
4.5
e6/l
732.7
2479.3
1.15
13
163
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
763
5980
1.43
13.18
2.6
2.6
u/l
56.0
58.3
0.97
697
5511
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1920
17911
1.69
12.30
4.4
4.0
mmol/l
1.3
1.3
1.03
1752
16357
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2077
19888
2.42
12.02
12.0
10.9
u/l
25.5
25.6
0.02
2011
19218
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1283
11110
1.39
11.81
2.8
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
490
3607
1.46
11.58
1.5
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
789
6355
1.38
11.14
6.3
5.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2067
19829
2.18
10.60
16.8
16.3
umol/l
72.1
73.3
1.38
2067
19824
(3024561) Albumin [Mass/volume] in Serum or Plasma
970
8124
1.35
10.52
4.3
4.8
g/l
36.4
35.6
5.23
902
7558
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1154
9933
1.35
10.41
5.2
6.4
umol/l
10.4
10.8
0.90
1091
9442
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
117
619
1.94
9.98
1.7
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1376
12209
1.35
9.92
3.3
3.1
u/l
42.2
48.4
2.49
1263
11327
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
568
4410
1.39
9.75
2.3
2.2
mg/l
2.7
3.0
1.46
481
3761
(3013826) Glucose [Moles/volume] in Serum or Plasma
1229
10736
1.34
9.75
4.2
4.6
mmol/l
6.6
6.7
0.49
1145
10069
(3035350) Ketones [Presence] in Urine by Test strip
1059
9065
1.33
9.59
3.8
3.8
estimate
0.0
0.0
0.00
212
1655
(40761511) CBC panel - Blood by Automated count
2017
19256
1.80
9.51
13.7
13.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
409
3009
1.44
9.50
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1895
17818
1.55
9.42
13.3
12.9
ml/min/173m2
81.0
80.2
1.23
1603
14721
(3015377) Calcium [Moles/volume] in Serum or Plasma
805
6644
1.34
9.26
2.9
3.5
mmol/l
2.4
2.4
0.25
694
5815
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1098
9477
1.33
9.25
5.7
6.7
mmol/l
1.2
1.2
1.18
923
8037
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
107
565
1.94
9.20
1.8
1.7
g/l
0.2
0.2
0.89
102
532
(3021601) Nitrite [Presence] in Urine by Test strip
1060
9122
1.32
9.03
5.0
5.1
estimate
0.0
0.0
0.50
213
1674
(3013650) Neutrophils [#/volume] in Blood by Automated count
1240
10915
1.32
8.96
9.0
9.4
e9/l
3.6
4.0
8.55
1104
9551
(3009261) Glucose [Presence] in Urine by Test strip
1066
9207
1.31
8.74
3.9
3.8
estimate
0.0
0.0
0.26
207
1641
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
108
588
1.88
8.49
1.7
1.6
g/l
1.2
1.2
0.52
103
555
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
206
1355
1.58
8.16
2.6
2.4
au/ml
39.2
25.8
—
10
68
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
260
1809
1.50
7.97
2.2
2.2
g/l
0.2
0.2
1.32
243
1705
(3028026) IgM [Mass/volume] in Serum or Plasma
176
1126
1.61
7.84
1.7
1.8
g/l
1.4
1.4
0.01
166
1022
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
630
5118
1.33
7.78
2.4
2.9
ng/l
628.4
1091.8
6.36
520
4347
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
39
146
2.70
7.59
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
39
146
2.70
7.59
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
39
146
2.70
7.59
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
211
1419
1.54
7.58
2.8
2.8
g/l
10.4
10.4
0.04
198
1288
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
740
6177
1.30
7.44
3.3
3.2
u/l
29.5
33.9
2.06
697
5869
(3024980) IgG subclass 4 [Mass/volume] in Serum
62
294
2.14
7.21
1.5
1.7
g/l
0.6
0.8
1.19
47
222
(3005322) IgE [Units/volume] in Serum or Plasma
185
1224
1.56
7.15
1.3
1.3
u/ml
112.4
178.7
1.73
174
1127
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
38
145
2.65
7.14
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
38
145
2.65
7.14
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
38
145
2.65
7.14
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
653
5391
1.30
7.05
1.8
1.7
mmol/l
1.3
1.4
2.92
569
4547
(3044889) 12 lead EKG panel
1471
13458
1.30
7.00
4.1
3.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
988
8610
1.27
6.94
5.0
6.0
mmol/l
1.2
1.2
1.50
887
7815
(3015736) pH of Urine
825
7037
1.28
6.88
3.6
3.5
—
5.8
—
0
5
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
275
1995
1.43
6.78
1.6
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
93
521
1.82
6.74
1.2
1.2
titre
115.0
81.7
—
10
36
(3022145) Colonoscopy Study observation
301
2222
1.41
6.73
1.3
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
198
1351
1.51
6.66
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
54
3.73
6.64
2.1
1.5
ug/l
8.5
8.9
0.22
20
54
(3007853) Bacteria identified in Skin by Aerobe culture
283
2083
1.41
6.43
1.6
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
53
250
2.15
6.28
1.7
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
49
225
2.21
6.21
1.7
1.6
%
52.9
56.9
0.25
28
147
(3017143) Hepatitis C virus Ab [Presence] in Serum
256
1867
1.42
6.12
1.4
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
581
4806
1.29
6.01
2.8
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
594
4929
1.28
5.99
2.9
3.0
e6/l
0.3
0.4
1.12
445
3694
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
37
153
2.44
5.96
1.2
1.1
u/ml
79.7
38.1
—
6
14
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
510
4156
1.30
5.91
1.6
1.8
mg/l
1.0
1.1
0.82
383
3194
(3019309) Folate [Moles/volume] in Red Blood Cells
411
3253
1.33
5.89
1.7
1.7
nmol/l
1229.2
1199.1
0.26
296
2449
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
39
167
2.36
5.83
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
125
796
1.61
5.73
2.1
2.0
u/l
40.7
39.5
0.27
108
707
(3032080) INR in Blood by Coagulation assay
826
7174
1.25
5.58
5.8
8.4
inr
1.1
1.2
2.78
258
2046
(3021589) Normoblasts [#/volume] in Blood
942
8301
1.24
5.58
9.7
9.4
e9/l
0.0
0.0
0.16
797
6787
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
486
3964
1.29
5.56
1.7
1.7
pmol/l
124102996.7
32733262.4
1.06
390
3275
(3004616) Nuclear Ab [Presence] in Serum
49
236
2.10
5.55
1.3
1.2
—
—
—
0
0
(4010399)
197
1399
1.45
5.45
1.5
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
353
2768
1.33
5.37
2.1
2.5
umol/l
14.0
13.1
1.44
323
2555
(3002582) Erythrocytes [#/volume] in Urine
630
5326
1.26
5.35
2.9
3.1
e6/l
31.5
74.7
1.63
480
4058
(3003327) Ova and parasites identified in Stool by Light microscopy
96
583
1.68
5.32
1.7
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
114
724
1.61
5.30
1.5
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
23
80
2.90
5.19
4.1
2.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
525
4360
1.27
5.16
3.9
3.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
134
890
1.54
5.15
1.9
2.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
325
2536
1.33
5.10
2.0
2.5
g/l
2.4
2.4
1.18
300
2347
(3023420) DNA double strand Ab [Units/volume] in Serum
44
211
2.11
5.07
2.1
1.4
iu/ml
28.8
29.8
—
5
11
(3020717) Zinc [Moles/volume] in Serum or Plasma
27
104
2.62
5.06
1.3
1.5
umol/l
26.6
24.7
0.11
27
99
(3027135) IgG subclass 1 [Mass/volume] in Serum
40
185
2.18
5.04
1.5
1.5
g/l
6.2
7.2
1.08
31
130
(3028192) IgG subclass 2 [Mass/volume] in Serum
40
185
2.18
5.04
1.5
1.5
g/l
3.0
2.9
0.14
32
130
(3024139) IgG subclass 3 [Mass/volume] in Serum
40
185
2.18
5.04
1.5
1.5
g/l
0.3
0.4
0.60
32
131
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
379
3027
1.31
5.04
2.4
2.6
e6/l
0.7
1.3
3.34
210
1695
(3008898) HLA-B27 [Presence]
98
610
1.64
4.96
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
85
510
1.69
4.95
2.1
2.1
mg/l
9.5
11.8
2.10
78
470
(3018095) Leukocytes [#/volume] in Urine
734
6359
1.23
4.93
3.6
3.6
e6/l
84.0
92.4
0.11
522
4418
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
664
5692
1.24
4.91
2.1
2.1
u/l
157.9
181.4
0.62
617
5340
(3000570) Elastase.pancreatic [Mass/mass] in Stool
95
592
1.63
4.80
1.3
1.4
ug/g
287.0
287.6
0.01
56
335
(46235355) HIV 1 and 2 tests - Meaningful Use set
315
2469
1.32
4.79
1.5
1.6
—
—
—
0
0
(4062490)
40
190
2.13
4.74
1.5
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
203
1489
1.40
4.71
2.7
2.9
g/l
68.1
66.8
2.19
189
1345
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
299
2345
1.32
4.52
6.1
6.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
187
1365
1.41
4.48
1.2
1.2
iu/ml
135.3
148.9
0.22
83
524
(3029937) Albumin [Presence] in Urine by Test strip
570
4852
1.24
4.43
4.3
4.2
estimate
0.0
0.0
1.28
210
1649
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
140
971
1.47
4.41
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
178
1292
1.41
4.40
2.6
2.9
e9/l
3.9
4.0
0.32
133
1015
(4094501)
85
528
1.64
4.38
1.1
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
32
145
2.23
4.28
1.2
1.1
u/ml
2.0
2.6
—
5
9
(3009508) Creatinine [Moles/volume] in Urine
669
5816
1.22
4.21
3.0
3.1
mmol/l
7.1
7.0
0.18
558
4879
(3012516) Albumin [Mass/volume] in Urine
641
5555
1.22
4.15
3.0
3.2
mg/l
859.1
365.5
0.92
358
3298
(3023323) Follitropin [Units/volume] in Serum or Plasma
111
747
1.51
4.07
1.4
1.3
iu/l
32.1
35.4
0.48
102
644
(3004588) Protein electrophoresis panel - Serum or Plasma
172
1261
1.40
4.03
2.5
2.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
445
3725
1.25
3.99
2.4
2.5
e6/l
4.3
6.6
5.20
393
3269
(3014051) Protein [Presence] in Urine by Test strip
75
465
1.64
3.92
2.2
2.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
19
71
2.69
3.82
1.3
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
781
6941
1.20
3.82
4.0
3.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
653
5708
1.21
3.82
3.5
4.1
ph
7.4
7.4
0.71
132
1077
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
300
2417
1.28
3.71
5.2
4.6
%
33.3
32.9
0.23
197
1605
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
50
3.01
3.69
1.3
1.4
%
42.5
28.2
—
10
32
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
151
1101
1.40
3.68
1.8
1.7
—
—
—
0
0
(3019225) pH of Specimen
245
1927
1.31
3.64
4.0
4.3
—
—
—
0
0
(3013512) EKG study
631
5523
1.20
3.61
3.8
3.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
113
785
1.46
3.59
2.2
2.2
nmol/l
14.1
12.5
1.17
101
693
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
776
6929
1.19
3.54
3.5
3.4
ng/l
308.2
47.8
0.45
483
4649
(3033658) Prothrombin time (PT) actual/Normal
547
4733
1.21
3.52
3.5
3.8
%
95.9
93.3
1.78
524
4604
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
110
764
1.46
3.50
1.3
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1618
15391
1.21
3.49
17.2
17.1
%
13.5
13.7
3.95
1594
15053
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
957
8712
1.18
3.45
3.8
3.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
369
3073
1.24
3.44
5.3
4.7
ug/l
1.8
2.4
2.41
333
2751
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
30
146
2.07
3.42
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
268
2155
1.28
3.37
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
337
2786
1.25
3.36
2.6
2.8
e6/l
2.8
3.3
0.33
169
1461
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
291
2367
1.27
3.33
2.2
2.5
%
23.8
22.6
0.71
240
2017
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
108
2.24
3.32
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
412
3487
1.22
3.30
3.3
3.5
ng/l
244.0
363.3
0.58
290
2647
(40760892) CBC W Ordered Manual Differential panel - Blood
475
4079
1.21
3.29
4.8
4.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
23
103
2.25
3.22
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
23
103
2.25
3.22
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
137
1009
1.38
3.18
2.2
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
300
2463
1.25
3.18
4.5
4.1
%
19.7
20.9
0.77
121
1132
(3020682) Albumin/Creatinine [Ratio] in Urine
658
5850
1.18
3.07
3.7
3.9
mg/mmol
5.2
8.1
1.19
369
3488
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
163
1242
1.34
3.06
1.9
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
558
4898
1.19
3.02
6.2
6.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
93
648
1.45
2.96
1.7
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
76
511
1.51
2.89
1.6
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
41
685
0.59
2.88
1.8
2.0
ug/l
1.1
2.0
0.58
34
606
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
25
122
2.06
2.87
1.3
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
261
2147
1.25
2.73
2.4
2.6
umol/l
6.5
7.6
0.59
224
1865
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
66
438
1.52
2.69
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
240
1961
1.25
2.67
4.2
4.4
u/l
224.3
250.0
3.33
227
1851
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
24
119
2.03
2.66
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
544
4812
1.17
2.65
2.4
2.5
umol/l
2243.8
5077.1
1.15
462
4172
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
410
3546
1.19
2.60
2.6
3.1
mmol/l
2.4
2.5
0.82
360
3128
(40768441) Liver Pathology biopsy report
28
149
1.89
2.56
1.1
1.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
181
1439
1.28
2.53
1.8
2.9
ng/l
97.9
172.6
3.17
158
1307
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
48
301
1.61
2.51
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
43
263
1.65
2.48
1.4
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
68
463
1.48
2.48
1.6
1.6
e6/l
12459.0
11053.3
0.13
51
346
(3042936) Bacteria identified in Isolate by Culture
305
2578
1.21
2.47
1.9
2.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
30
166
1.82
2.45
1.4
2.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
675
1.39
2.42
2.4
2.6
g/l
10.2
10.2
0.01
78
571
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
97
713
1.38
2.35
1.6
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
38
229
1.67
2.33
2.0
1.9
pmol/l
216.4
204.9
0.27
38
215
(3036481) Cortisol [Moles/volume] in Serum or Plasma
219
1802
1.24
2.31
2.6
2.2
nmol/l
368.9
369.3
0.01
209
1652
(4035726)
222
1830
1.24
2.30
1.3
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
187
1514
1.26
2.28
2.6
2.5
ml/min/173m2
67.7
66.1
0.26
84
607
(3041096) Erythrocytes [Presence] in Urine by Automated
540
4828
1.16
2.27
3.4
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1733
16771
1.17
2.25
15.6
15.0
%
40.3
39.5
4.30
1216
11976
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
66
2.28
2.24
1.4
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
450
3978
1.17
2.19
4.3
4.2
kg/l
1.0
1.0
0.49
65
580
(3026008) Bacteria identified in Urine by Culture
646
5864
1.15
2.19
3.2
3.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
80
2.13
2.18
1.7
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
80
2.13
2.18
1.7
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
51
337
1.53
2.17
1.3
1.3
u/l
11.7
13.3
0.31
39
267
(3002256) Pathology report gross observation
292
2490
1.20
2.17
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
218
1808
1.23
2.15
3.6
2.9
ug/l
0.6
0.7
2.16
137
1157
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
41
260
1.59
2.10
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
43
2.57
2.09
1.0
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
737
1.35
2.09
2.4
2.5
g/l
3.7
3.7
0.26
71
521
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
694
1.36
2.08
2.2
2.6
g/l
3.0
3.1
0.91
73
533
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
738
1.34
2.07
2.4
2.5
g/l
7.4
7.4
0.09
75
552
(3021788) Differential panel - Synovial fluid
49
325
1.52
2.07
1.6
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
56
2.33
2.05
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
41
262
1.58
2.04
1.4
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
50
2.41
2.02
1.0
1.4
%
90.8
90.5
—
5
26
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
26
3.08
2.01
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
738
1.33
1.94
2.4
2.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
150
1210
1.26
1.92
2.9
3.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
151
1222
1.25
1.89
1.3
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
52
2.32
1.87
1.0
1.0
—
—
—
0
0
(44813793)
24
136
1.77
1.87
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
69
501
1.39
1.86
1.5
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
37
237
1.57
1.85
1.6
2.3
mg/l
16.9
26.4
—
10
66
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
17
3.54
1.84
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
40
2.51
1.83
1.2
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
182
1511
1.22
1.81
3.3
3.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
79
590
1.35
1.80
2.3
2.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
16
80
2.01
1.80
2.0
2.2
mmol/l
7.8
10.3
1.68
11
63
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
77
573
1.36
1.80
2.1
2.5
g/l
38.9
37.8
1.09
67
493
(3025468) Yersinia sp identified in Specimen by Organism specific culture
39
255
1.54
1.79
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
39
255
1.54
1.79
1.4
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
29
2.77
1.79
1.0
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
31
192
1.62
1.78
1.3
1.3
e6/l
88477.7
64724.1
0.11
19
136
(3012095) Magnesium [Moles/volume] in Serum or Plasma
347
3059
1.16
1.76
2.8
3.3
mmol/l
0.8
0.8
0.09
321
2837
(3005988) Vibrio sp identified in Specimen by Organism specific culture
39
257
1.53
1.74
1.4
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
54
2.23
1.74
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
76
568
1.35
1.73
1.7
1.6
iu/ml
0.0
0.1
0.43
13
110
(3034860) Kappa light chains.free [Mass/volume] in Serum
75
560
1.35
1.72
3.6
3.9
mg/l
47.1
63.4
0.39
60
463
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
48
0.00
1.69
0.0
1.5
—
4.2
—
0
38
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
49
0.00
1.68
0.0
1.4
—
26.1
—
0
42
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
27
164
1.65
1.68
1.0
1.1
u/ml
0.0
0.2
—
7
44
(3025941) Bacteria identified in Stool by Culture
130
1052
1.25
1.66
1.2
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
25
2.81
1.65
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
64
471
1.37
1.62
1.2
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
26
159
1.64
1.59
1.2
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
26
2.70
1.58
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
26
2.70
1.58
1.0
1.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
74
561
1.33
1.56
3.6
3.9
mg/l
89.0
49.4
0.51
60
466
(3000492) Spirometry study
212
1816
1.19
1.55
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
181
1530
1.20
1.53
4.1
4.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
68
511
1.34
1.53
2.2
2.6
g/l
0.0
0.0
0.00
63
472
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
143
0.42
1.51
1.5
1.5
umol/l
8.3
12.0
—
6
135
(3047181) Lactate [Moles/volume] in Blood
72
547
1.33
1.51
3.9
8.2
mmol/l
1.1
1.3
1.20
66
484
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
21
2.86
1.50
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
157
1312
1.21
1.50
1.7
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
231
0.52
1.50
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
73
558
1.32
1.47
2.1
2.6
g/l
0.0
0.0
0.51
68
512
(1002224) Polysomnography panel
94
744
1.28
1.47
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
169
0.47
1.46
3.1
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
27
171
1.59
1.46
2.4
2.0
e9/l
0.9
1.1
0.56
17
107
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
38
2.37
1.45
1.4
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
72
551
1.32
1.45
1.8
1.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
10
201
0.50
1.43
2.6
1.4
g/l
30.6
33.5
—
10
179
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
68
517
1.33
1.43
2.2
2.6
g/l
0.0
0.0
0.00
63
473
(3023520) Reticulocytes [#/volume] in Blood
167
1413
1.20
1.42
2.9
2.7
e9/l
72.0
72.2
0.01
128
1074
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
90
713
1.27
1.41
1.8
1.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
53
2.08
1.38
1.5
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
23
2.61
1.36
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
22
346
0.63
1.34
4.2
3.2
nmol/l
0.7
0.8
1.12
14
271
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
80
629
1.28
1.34
2.1
2.7
g/l
1.3
0.9
0.23
72
553
(40760888) Immunoglobulin light chains.free panel - Serum
55
410
1.35
1.33
3.6
4.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
22
136
1.62
1.32
1.6
1.9
%
13.5
14.0
—
10
47
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
70
543
1.30
1.30
3.8
3.9
ratio
4.1
1.6
—
6
45
(3026782) Osmolality of Urine
380
3445
1.13
1.29
2.7
2.7
mosm/kgh2o
490.6
527.4
3.00
321
2948
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
34
2.36
1.29
1.4
1.4
ng/l
97.9
80.5
—
8
34
(1761482) Bacteria [#/volume] in Urine by Culture
31
448
0.69
1.28
5.9
4.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
252
1.44
1.26
1.0
1.1
u/ml
4.4
4.0
0.06
21
118
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
77
1.82
1.25
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
41
295
1.40
1.24
1.4
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
29
195
1.49
1.24
1.1
1.1
u/ml
1.1
2.4
1.02
14
75
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
49
2.05
1.22
1.2
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
19
2.64
1.21
4.6
5.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
14
78
1.80
1.21
3.1
3.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
132
1.60
1.20
1.9
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
25
164
1.53
1.20
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
225
1982
1.15
1.20
1.5
1.8
%
1.5
1.4
0.20
203
1731
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
157
1.53
1.17
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
32
223
1.44
1.16
1.0
1.1
u/ml
0.1
2.1
2.15
11
56
(4211845)
15
87
1.73
1.15
3.1
3.5
—
—
—
0
0
(4034850)
48
632
0.75
1.15
14.3
9.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
46
343
1.35
1.15
1.2
1.3
—
77.1
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
116
971
1.21
1.15
1.4
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
37
266
1.40
1.14
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
112
935
1.21
1.14
6.9
11.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
60
466
1.30
1.14
1.9
1.7
mu/l
308.4
309.8
0.01
53
419
(3004775) Volume in Urine collected for unspecified duration
8
155
0.51
1.13
1.6
2.3
ml
888.8
633.8
—
8
105
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
183
1.48
1.13
3.1
3.0
%
58.9
57.2
0.17
22
123
(3045788) Cell count panel - Pleural fluid
8
156
0.51
1.13
3.4
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
30
2.34
1.12
1.0
1.2
umol/24h
1.4
1.7
—
7
30
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
40
293
1.37
1.12
1.1
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
22
143
1.54
1.11
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
41
302
1.36
1.11
1.3
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
195
0.56
1.10
3.1
2.2
—
—
—
0
0
(4024509)
30
209
1.44
1.10
2.0
1.7
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
7
31
2.26
1.10
2.1
2.1
—
3.5
—
0
13
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
202
1780
1.15
1.09
2.4
2.3
u/l
58.2
38.4
0.34
169
1528
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
63
496
1.28
1.09
1.5
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
18
113
1.60
1.05
1.1
1.7
ug/l
3.0
5.9
0.55
13
87
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
80
652
1.24
1.04
1.6
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
213
1891
1.14
1.04
2.7
3.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
166
1449
1.16
1.03
3.6
4.3
%
0.1
0.5
0.75
38
363
(3003338) MCHC [Mass/volume]
1593
15564
1.09
1.02
18.9
18.1
g/l
332.4
331.5
3.35
1586
15466
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
25
171
1.47
1.02
1.8
1.5
%
35.3
38.1
0.11
13
109
(3024891) Influenza virus A+B Ag [Presence] in Specimen
35
473
0.74
1.02
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
109
0.46
1.00
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
37
274
1.36
0.99
1.1
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
149
1295
1.16
0.98
2.8
3.3
pmol/l
4.2
4.5
4.29
133
1147
(3016650) Hepatitis A virus Ab [Presence] in Serum
39
292
1.34
0.98
1.1
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
22
148
1.49
0.98
1.9
1.9
%
49.2
46.2
—
5
17
(3000034) Microalbumin [Mass/volume] in Urine
25
173
1.45
0.97
2.7
2.8
mg/l
11.0
25.2
0.94
16
118
(40762365) Oxygen content in Arterial blood by calculation
0
30
0.00
0.97
0.0
3.1
—
15.3
—
0
25
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
10
54
1.86
0.96
2.0
2.7
—
53.6
—
0
10
(3011985) Renin [Units/volume] in Plasma
37
277
1.34
0.94
1.9
1.5
mu/l
60.9
41.5
0.48
32
253
(4146454)
30
217
1.39
0.93
2.8
2.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
143
0.56
0.93
3.8
6.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
481
1.25
0.93
1.4
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
49
383
1.29
0.92
3.3
3.6
%
59.1
57.3
0.51
49
383
(3036782) Glucose [Moles/volume] in Pleural fluid
8
146
0.55
0.92
1.6
1.3
mmol/l
5.2
6.4
—
8
133
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
13
78
1.67
0.91
1.8
2.4
umol/l
69.4
52.4
—
7
57
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
16
102
1.57
0.90
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
38
288
1.33
0.90
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
167
1477
1.14
0.89
3.6
3.9
%
0.8
0.6
0.50
35
334
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
128
0.55
0.88
1.7
1.3
u/l
281.4
328.2
—
7
122
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
56
1.79
0.87
1.0
2.2
ug/l
0.7
1.5
—
10
50
(44790047)
14
217
0.64
0.87
1.4
1.4
—
—
—
0
0
(44790049)
14
217
0.64
0.87
1.4
1.4
—
—
—
0
0
(44790048)
14
217
0.64
0.87
1.4
1.4
—
—
—
0
0
(44806118)
14
217
0.64
0.87
1.4
1.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
30
2.00
0.87
1.7
1.5
%
109.0
107.7
—
6
30
(3052851) Hemolysis interference index of Serum or Plasma
69
568
1.22
0.86
2.8
3.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
167
1482
1.14
0.85
2.0
2.3
ug/l
7.7
6.8
0.19
140
1302
(3017704) Immunofixation for Urine
16
104
1.54
0.84
2.1
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
1.8
2.4
umol/l
15.6
20.0
—
6
31
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
67
808
0.82
0.83
2.3
2.6
%
1.2
1.2
0.10
67
803
(3009466) Valproate [Moles/volume] in Serum or Plasma
18
261
0.69
0.82
3.1
5.4
umol/l
345.5
374.9
0.31
12
226
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
32
1.88
0.81
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
49
391
1.26
0.81
1.3
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
14
89
1.58
0.81
2.5
3.3
ph
7.4
7.4
—
5
30
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
178
1593
1.13
0.81
3.6
3.8
mmol/l
1.2
1.2
0.36
161
1390
(3011288) Drugs identified in Urine by Screen method
33
250
1.33
0.80
1.6
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
49
392
1.26
0.80
1.3
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
58
1.73
0.79
1.4
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
33
1.82
0.79
1.7
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
67
803
0.83
0.79
2.2
4.1
mmol/l
24.6
24.3
0.39
60
721
(3028300) Cannabinoids [Presence] in Urine
49
393
1.25
0.78
1.3
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
540
0.79
0.78
2.6
3.4
u/ml
0.3
0.4
0.48
21
306
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
199
0.65
0.78
1.2
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
199
1.36
0.78
1.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
182
1.38
0.78
4.6
3.7
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
27
0.00
0.77
0.0
1.1
—
2.3
—
0
14
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
183
1.37
0.76
1.0
1.1
u/ml
4.1
3.2
0.18
12
71
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
279
1.30
0.76
1.3
1.2
u/ml
1.8
3.9
0.78
13
75
(3024263) Appearance of Synovial fluid
15
99
1.52
0.75
1.1
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
173
0.63
0.75
4.1
2.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
137
1543
0.88
0.74
2.6
3.7
mmol/l
2.1
2.0
0.05
113
1271
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
306
2834
1.09
0.74
1.7
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
108
1.49
0.73
2.6
2.5
%
37.7
42.3
—
9
32
(3027945) Reticulocytes/100 erythrocytes in Blood
207
1882
1.11
0.73
2.6
2.6
%
1.8
1.8
0.38
188
1679
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
30
228
1.32
0.73
1.4
1.5
nmol/l
0.3
0.3
0.03
20
169
(3035637) Corticotropin [Mass/volume] in Plasma
30
228
1.32
0.73
1.5
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
159
0.63
0.72
2.7
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
28
211
1.33
0.72
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
42
335
1.26
0.72
1.5
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
110
0.54
0.72
1.2
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
117
1.46
0.71
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
40
1.75
0.71
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
67
564
1.19
0.70
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
240
0.71
0.70
1.6
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
170
1535
1.12
0.69
3.7
4.2
%
0.3
0.1
0.88
40
427
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
442
0.79
0.69
1.5
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
42
1.67
0.68
1.1
1.9
—
—
—
0
0
(3016750) Collection duration of Urine
7
117
0.60
0.68
1.6
2.2
min
467.4
494.1
—
7
89
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
33
258
1.28
0.67
1.4
1.4
pmol/l
268.0
299.4
0.39
24
202
(3017181) Myelocytes/100 leukocytes in Blood
178
1615
1.11
0.67
3.8
4.2
%
1.6
0.9
0.77
42
465
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
153
1.38
0.67
1.2
1.2
u/ml
1.1
0.6
—
9
66
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
476
4509
1.07
0.67
2.3
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
66
558
1.19
0.67
1.2
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
43
1.63
0.67
6.0
3.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
94
0.53
0.66
4.6
3.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
162
1463
1.12
0.66
1.4
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
30
384
0.78
0.66
4.3
3.7
mg/l
13.7
24.8
3.07
19
240
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
95
0.53
0.66
1.0
1.7
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
28
1.79
0.66
1.0
1.2
—
67.8
—
0
6
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
34
268
1.27
0.65
1.7
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
44
358
1.23
0.65
1.3
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
190
0.68
0.65
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
190
0.68
0.65
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
331
1.24
0.65
1.4
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
259
2398
1.09
0.65
4.1
5.6
mmol/l
1.0
1.0
1.75
237
2216
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
44
1.59
0.65
1.3
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
32
251
1.28
0.64
1.1
1.1
u/ml
1.7
2.8
—
10
107
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
29
1.73
0.64
1.2
2.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
189
0.69
0.63
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
189
0.69
0.63
1.2
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
303
0.76
0.63
1.1
1.1
iu/ml
19.4
1968.9
—
7
66
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
279
1.26
0.62
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
101
0.59
0.62
1.5
1.6
—
—
—
0
0
(4015189)
8
49
1.63
0.62
3.5
2.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
49
1.63
0.62
3.9
2.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
65
554
1.18
0.61
1.2
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
30
1.67
0.61
1.0
1.2
—
66.7
—
0
6
(3000012) Reticulocyte production index
14
96
1.46
0.61
1.1
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
50
1.60
0.61
1.0
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
20
0.00
0.60
0.0
1.3
—
2220.1
—
0
11
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
20
0.00
0.60
0.0
8.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
218.1
—
0
12
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
23
0.00
0.58
0.0
1.1
—
3.7
—
0
12
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
23
0.00
0.58
0.0
1.6
—
10.3
—
0
11
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
2.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
246
1.26
0.58
1.0
1.1
u/ml
0.3
1.7
1.65
17
97
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
31
387
0.80
0.58
2.3
1.9
nmol/l
1.1
0.8
0.73
24
318
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
89
1.46
0.58
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
87
988
0.88
0.57
1.8
1.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
35
1.72
0.57
1.0
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
72
625
1.16
0.56
2.0
3.3
g/l
0.2
0.2
2.30
21
242
(3022217) INR in Platelet poor plasma by Coagulation assay
239
2223
1.08
0.56
16.2
22.2
inr
1.1
1.3
3.19
41
300
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
21
159
1.32
0.55
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
16
116
1.38
0.54
2.6
2.1
ug/l
2.7
2.1
0.27
11
102
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
82
1.47
0.54
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
82
1.47
0.54
1.4
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
60
1.50
0.54
1.7
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
126
0.63
0.54
4.3
3.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
76
665
1.15
0.54
2.0
1.8
mg/l
2.9
3.9
0.44
56
480
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
30
370
0.81
0.52
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
30
370
0.81
0.52
1.1
1.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
6
96
0.62
0.52
1.8
1.2
u/l
8.8
10.7
—
6
83
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
100
0.60
0.51
1.3
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
203
0.74
0.51
1.1
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
248
0.76
0.51
1.3
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
370
1.19
0.51
3.2
2.2
g/l
125.9
129.3
0.47
34
270
(3020891) Body temperature
63
723
0.87
0.50
2.7
4.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
284
2675
1.07
0.49
1.6
2.1
s
29.1
29.4
0.49
277
2595
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
101
1.39
0.49
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
46
390
1.18
0.49
2.3
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
37
443
0.83
0.49
2.2
2.4
ug/min
73.4
104.2
0.43
23
265
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
18
136
1.33
0.49
1.0
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
54
625
0.86
0.48
2.5
3.6
mmol/l
1.4
1.4
0.17
54
615
(40768800) Prostate Pathology biopsy report
24
190
1.27
0.48
1.4
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
35
290
1.21
0.47
1.1
1.1
u/ml
3.1
1.4
0.32
15
113
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
505
0.85
0.47
1.2
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
85
1.41
0.47
1.3
2.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
111
1.35
0.46
1.4
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
49
1.43
0.46
3.4
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
49
1.43
0.46
3.4
3.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
105
952
1.11
0.45
3.7
3.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
274
1.21
0.44
1.4
1.2
u/ml
5.4
5.5
0.01
16
104
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
469
1.16
0.44
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
112
1.34
0.44
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
30
247
1.22
0.44
2.6
2.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
152
0.72
0.44
1.1
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
54
470
1.15
0.43
1.3
1.3
miu/ml
129.5
214.4
1.56
23
216
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
140
0.71
0.43
1.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
32
382
0.84
0.43
2.3
2.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
166
1543
1.08
0.43
3.0
3.6
ng/l
90.0
83.6
0.27
138
1323
(3052592) Norovirus Ag [Presence] in Stool
5
32
1.56
0.42
1.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
35
295
1.19
0.41
1.3
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
132
1430
0.92
0.41
7.9
8.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
29
240
1.21
0.41
1.2
1.3
mmol/l
7.3
7.5
0.15
23
170
(3041806) Other cells [#/volume] in Blood by Manual count
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.0
—
0
8
(3006653) Thiamine [Moles/volume] in Blood
14
105
1.34
0.41
1.6
1.3
nmol/l
133.4
136.3
0.08
14
105
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
27
222
1.22
0.41
1.2
1.2
u/l
40.3
54.4
1.55
14
159
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.1
—
28.1
—
0
10
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
444
0.85
0.40
1.4
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
682
6624
1.04
0.40
2.8
2.9
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.8
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.8
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.8
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.8
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
45
390
1.16
0.39
1.4
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
171
0.76
0.39
2.7
2.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
47
409
1.15
0.39
2.9
2.9
mmol/l
24.7
25.0
0.25
39
359
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
259
0.81
0.39
1.1
1.6
—
—
—
0
0
(4306422)
33
279
1.19
0.38
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
77
694
1.11
0.38
2.3
3.6
u/ml
96.6
2291.5
0.88
64
590
(3014111) Lactate [Moles/volume] in Serum or Plasma
143
1537
0.93
0.38
6.9
6.8
mmol/l
1.2
1.3
0.83
135
1484
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
66
1.37
0.38
2.4
5.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
66
1.37
0.38
1.1
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
52
458
1.14
0.37
2.2
3.2
mg/l
1.2
1.6
3.19
46
429
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
98
1.33
0.37
1.4
1.3
—
—
—
0
0
(4281824)
23
279
0.82
0.37
1.0
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
119
1099
1.09
0.37
4.5
7.6
mmol/l
24.1
24.7
1.56
111
1030
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
158
0.76
0.37
1.2
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
115
0.69
0.37
1.4
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
15
116
1.30
0.37
2.8
2.2
e6/l
876.9
743.3
—
8
49
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
30
354
0.85
0.37
1.2
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
71
1.27
0.36
2.0
2.0
ug/l
66.7
61.2
—
9
71
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
180
1.22
0.36
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
76
0.66
0.35
2.0
2.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
77
0.65
0.35
2.0
2.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
199
1.21
0.35
2.9
3.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
108
1168
0.92
0.34
3.6
5.5
—
—
—
0
0
(4268621)
23
190
1.21
0.34
2.3
2.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
101
930
1.09
0.34
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
156
0.77
0.34
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
21
172
1.22
0.34
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
483
4676
1.04
0.34
3.8
4.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
35
302
1.16
0.34
1.3
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
100
1.30
0.33
1.4
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
188
0.80
0.33
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
500
4849
1.04
0.32
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
34
294
1.16
0.32
1.4
1.4
u/ml
96.5
110.2
0.58
11
58
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
2.8
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
154
0.78
0.32
1.2
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
92
1.31
0.31
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
153
0.78
0.30
1.2
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
16
129
1.24
0.30
1.5
1.9
umol/l
10.4
5.4
0.78
11
79
(21494814) CD8 cells/100 lymphocytes in Specimen
11
84
1.31
0.30
1.7
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
57
515
1.11
0.29
1.8
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
163
0.80
0.29
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
607
5922
1.03
0.29
2.3
2.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
76
1.32
0.28
1.6
1.1
miu/ml
1136.6
1667.2
—
10
76
(3044927) Protein electrophoresis panel - Urine
22
186
1.18
0.28
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
67
614
1.09
0.27
1.3
1.3
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
8
64
1.25
0.27
1.3
1.4
%
42.8
45.0
—
8
55
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
198
2074
0.95
0.27
3.0
4.1
ug/l
4.0
24.2
2.35
153
1678
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
171
0.82
0.26
1.4
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
72
0.69
0.26
1.0
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
141
1.21
0.26
1.4
2.1
%
12.7
10.8
1.34
17
141
(3021901) Oxygen saturation in Capillary blood
33
291
1.14
0.26
3.2
2.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
56
511
1.10
0.25
1.6
1.9
iu/l
2.6
5.3
2.87
17
169
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
37
330
1.12
0.25
1.4
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
75
1.20
0.25
2.0
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
2.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
2.0
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
29
329
0.88
0.24
1.4
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
133
1.20
0.24
1.8
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
37
331
1.12
0.24
1.7
1.6
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
15
124
1.21
0.24
1.1
1.6
mmol/l
6.6
6.7
—
9
81
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
81
755
1.08
0.24
2.3
1.8
g/l
1.5
1.6
0.66
65
655
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
408
1.11
0.23
2.2
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
190
0.84
0.23
1.6
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
25
218
1.15
0.23
3.0
2.2
pg
32.3
32.3
0.01
25
218
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
243
0.86
0.23
1.3
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
327
0.89
0.23
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
162
1.17
0.23
1.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
162
1.17
0.23
1.7
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
162
1.17
0.23
1.7
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
40
1.25
0.22
1.2
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
53
487
1.09
0.22
1.3
1.2
mg/l
427.2
518.1
2.14
47
464
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
231
0.86
0.22
1.2
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
3611.8
—
0
6
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
11
0.00
0.21
0.0
1.6
—
5.8
—
0
6
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
13.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
22.0
—
0
12
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
8.4
—
0
12
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
37.9
—
0
12
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
38
344
1.11
0.21
2.2
1.9
u/l
118.9
1960.5
—
7
143
(4198724)
5
43
1.16
0.21
1.8
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
145
0.83
0.21
1.2
1.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(3025315) Body weight
0
13
0.00
0.21
0.0
5.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
13
0.00
0.21
0.0
5.5
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3042631) Mycobacterium sp identified in Specimen
28
249
1.13
0.20
2.0
2.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
185
1780
1.04
0.20
6.7
8.1
%
97.1
95.8
5.54
178
1725
(46235168) Fasting glucose [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.4
—
6.4
—
0
6
(3048879) Bone marrow aspiration report
6
48
1.25
0.20
2.2
2.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
175
1682
1.04
0.20
7.0
8.4
g/l
123.1
120.8
0.89
168
1628
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
108
1.20
0.20
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
108
1.20
0.20
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
42
384
1.10
0.20
1.1
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
107
1126
0.95
0.19
8.8
8.6
%
95.3
94.0
5.47
107
1119
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
26
231
1.13
0.19
3.3
3.3
nmol/l
2.4
29.4
0.60
26
226
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
186
0.86
0.19
1.4
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
24
270
0.89
0.19
1.5
1.8
mmol/l
1.6
1.6
0.26
24
263
(3023410) Appearance of Cerebral spinal fluid
22
194
1.14
0.18
1.1
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
135
1294
1.05
0.18
3.4
3.8
u/ml
41.8
61.8
0.60
127
1253
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
206
0.87
0.18
1.6
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
59
1.19
0.18
1.1
1.0
—
—
—
0
0
(3010421) pH of Blood
44
476
0.92
0.17
3.2
3.7
ph
7.4
7.4
0.09
38
385
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
87
917
0.95
0.17
10.0
9.3
mmol/l
24.3
24.5
0.36
81
865
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
138
1.16
0.17
1.4
1.6
u/l
7.3
5.0
—
6
64
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
46
426
1.08
0.17
1.2
1.3
e6/l
55.4
23.2
0.31
30
327
(3028626) Oxygen [Partial pressure] in Capillary blood
38
349
1.09
0.17
3.0
2.7
kpa
8.3
8.1
0.31
33
322
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
63
1.11
0.17
1.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
148
1.15
0.17
2.4
2.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
69
0.72
0.17
1.0
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
46
427
1.08
0.16
1.3
1.4
e6/l
121.0
1451.2
1.32
34
349
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
8
69
1.16
0.16
1.4
1.2
%
105.1
110.8
—
8
60
(3023183) Ammonium ion [Moles/volume] in Plasma
36
391
0.92
0.16
3.2
3.1
umol/l
30.5
35.4
0.81
31
335
(3051593) INR in Capillary blood by Coagulation assay
8
72
1.11
0.16
1.0
12.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
72
1.11
0.16
1.9
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
24
266
0.90
0.15
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
24
266
0.90
0.15
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
41
380
1.08
0.15
1.4
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
119
0.84
0.15
1.5
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
79
1.14
0.15
1.0
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
226
2200
1.03
0.15
6.2
6.7
mmol/l
104.5
104.2
0.65
220
2156
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
108
1036
1.04
0.15
6.6
6.7
mmol/l
24.9
25.1
0.20
108
1027
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
11
93
1.18
0.14
2.0
1.7
nmol/l
4.2
5.3
—
6
77
(40767503) Oxygen content in Capillary blood by calculation
38
353
1.08
0.14
3.1
2.5
%
15.6
16.3
0.46
20
180
(3036489) Thrombin time
72
685
1.05
0.14
1.7
1.9
s
20.5
21.3
1.38
62
599
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
180
1.11
0.13
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
26
238
1.09
0.13
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
17
190
0.89
0.13
2.4
2.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
109
1051
1.04
0.13
3.5
3.4
kpa
5.1
5.2
0.39
100
978
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
30
277
1.08
0.12
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
127
0.87
0.12
3.6
2.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
104
1.15
0.12
1.1
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
54
568
0.95
0.11
3.4
2.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
108
1116
0.97
0.11
8.7
8.6
%
0.7
0.7
0.14
108
1110
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
279
1.08
0.11
1.5
1.3
nmol/l
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
309
1.07
0.10
1.4
1.2
u/ml
302.2
267.7
0.36
20
182
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
58
554
1.05
0.10
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
96
1.15
0.10
2.6
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
107
1038
1.03
0.10
3.6
3.4
ph
7.4
7.4
0.23
17
137
(1616796) Gas panel - Central venous blood
35
371
0.94
0.09
4.5
3.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
109
1122
0.97
0.09
8.6
8.5
%
1.3
1.3
0.05
109
1115
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
381
0.94
0.09
1.6
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
103
1000
1.03
0.09
3.6
3.4
mmol/l
1.6
1.8
0.25
77
764
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
37
350
1.06
0.09
1.3
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
227
0.92
0.09
1.3
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
11
97
1.13
0.09
1.6
2.4
—
38.5
—
0
8
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
26
278
0.93
0.09
1.3
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
54
1.11
0.09
1.7
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
55
1.09
0.09
1.7
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
58
1.03
0.08
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
113
0.88
0.08
1.1
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
60
0.83
0.08
1.2
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
65
0.77
0.08
1.2
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
64
1.09
0.08
1.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
64
1.09
0.08
1.6
1.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
199
2024
0.98
0.08
6.5
7.6
kpa
5.1
5.1
0.39
192
1944
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
68
1.03
0.07
1.0
1.1
iu/ml
118.5
209.5
—
7
68
(3028433) Virus identified in Specimen by Culture
7
68
1.03
0.07
1.0
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
199
2023
0.98
0.07
6.4
7.6
kpa
13.1
12.6
0.66
192
1941
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
154
1570
0.98
0.07
1.7
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
75
1.07
0.07
1.3
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
108
1.11
0.07
1.0
1.1
u/l
1.1
1.1
—
6
61
(3014271) Vancomycin [Susceptibility]
7
84
0.83
0.07
3.6
2.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
85
0.82
0.07
1.7
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
85
1.06
0.07
1.2
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
93
0.86
0.06
1.1
1.1
—
—
—
0
0
(4027681)
9
104
0.86
0.06
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
101
1032
0.98
0.06
1.5
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
99
1011
0.98
0.06
1.4
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
129
1.09
0.05
1.1
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
38
395
0.96
0.05
3.5
3.9
kpa
8.7
8.6
0.25
38
387
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
197
1996
0.99
0.05
1.6
1.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
151
0.93
0.05
1.6
2.2
u/field
1.0
2.2
—
7
67
(3013290) Carbon dioxide [Partial pressure] in Blood
38
394
0.96
0.05
3.5
3.9
kpa
5.1
5.1
0.03
38
386
(3022313) Gas panel - Capillary blood
77
754
1.02
0.04
3.4
3.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
38
393
0.97
0.04
3.5
3.9
mmol/l
2.4
2.7
0.36
26
274
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
109
0.92
0.04
1.2
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
53
517
1.03
0.04
2.1
2.3
%
202.2
190.8
0.36
47
495
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
197
1989
0.99
0.03
1.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
153
1513
1.01
0.03
1.4
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
13
139
0.93
0.03
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
203
2013
1.01
0.03
6.4
7.6
mmol/l
0.7
1.3
2.04
158
1611
(3003181) Sodium [Moles/volume] in Urine
35
341
1.03
0.02
1.5
1.4
mmol/l
60.7
59.6
0.06
27
275
(3020779) Urea [Moles/volume] in Serum or Plasma
152
1530
0.99
0.01
4.5
7.8
mmol/l
7.0
9.3
5.65
144
1462
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
106
1051
1.01
0.01
1.6
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
20
193
1.04
0.01
3.0
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
24
233
1.03
0.01
1.1
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
11
104
1.06
0.01
1.8
1.8
u/field
1.3
2.2
—
6
77
(3014148) Varicella zoster virus Ab [Titer] in Serum
19
196
0.97
0.00
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
189
1.01
0.00
1.6
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
209
1.00
0.00
3.3
3.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
32
321
1.00
0.00
1.5
1.3
nmol/l
0.6
0.6
0.06
32
307
(3004451) EKG impression Narrative
10
96
1.04
0.00
1.9
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
146
1.03
0.00
1.4
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
214
0.98
0.00
1.3
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
21
208
1.01
0.00
1.6
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
37
368
1.01
0.00
1.8
3.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
127
1.02
0.00
1.5
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
16
157
1.02
0.00
2.1
2.0
—
1.3
—
0
8
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
13.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.2
—
0
6
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
53
0.94
0.00
1.4
2.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
30
300
1.00
0.00
1.4
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
4.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
10
100
1.00
0.00
1.1
1.4
mmol/l
5.5
6.0
—
10
93
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
4.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
67
0.90
0.00
1.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
91
0.99
0.00
1.3
2.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.2
—
78.0
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
74
0.95
0.00
1.0
1.3
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.8
—
0
5
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
83
0.96
0.00
2.4
2.0
ug/l
25.2
114.4
—
8
72
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
16.3
—
0
9
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
5.1
—
376.3
—
0
8
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
8
88
0.91
0.00
1.3
1.1
%
99.0
94.4
—
8
69
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_ORAL_LICHEN_PLANUS_INCLAVO – Oral lichen ruber planus, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).